Preferred Pharmaceuticals, Inc. recalls
Every recall we track for Preferred Pharmaceuticals, Inc. — 56 in all, from 2018–2026 — plus the complaints and injury reports the public filed about them. 2 are rated “stop using now”.
Recalls per year, by danger level
Recalls from Preferred Pharmaceuticals, Inc. peaked in 2023 (22); 56 since 2017. 4% rated “stop using now”.
All FDA recall records for Preferred Pharmaceuticals, Inc. since 2017, counted by recall date (one bar per calendar year; 2026 is partial). Danger level is GovInfoNow’s plain-language rating; “not yet rated” records are still being written up.
| Year | Stop using now | Use caution | Lower risk | Not yet rated | Total |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 1 | 1 |
| 2019 | 1 | 1 | 0 | 5 | 7 |
| 2020 | 1 | 1 | 0 | 7 | 9 |
| 2021 | 0 | 0 | 3 | 0 | 3 |
| 2022 | 0 | 2 | 2 | 4 | 8 |
| 2023 | 0 | 1 | 4 | 17 | 22 |
| 2024 | 0 | 0 | 0 | 2 | 2 |
| 2025 | 0 | 1 | 0 | 1 | 2 |
| 2026 (to date) | 0 | 2 | 0 | 0 | 2 |
Most common reasons for Preferred Pharmaceuticals, Inc. recalls
What to do if you have a recalled Preferred Pharmaceuticals, Inc. product
- Match the NDC and lot number on your bottle or box to the recall.
- Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first.
- Report side effects to FDA MedWatch.
All Preferred Pharmaceuticals, Inc. recalls
33 shown- Use cautionDrug
Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,
Preferred Pharmaceuticals recalls specific lots of Lidocaine Ointment USP 5% due to failed content uniformity specifications. Check your lot numbers.
Preferred PharmaceuticalsSep 28, 2026 - Use cautionDrug
Preferred Pharmaceuticals, Inc. recalls Artificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles,
Preferred Pharmaceuticals recalls Geri-Care Artificial Tears due to lack of sterility assurance. Check lot numbers F1924R, F2024G, and others immediately.
Geri-CareMar 25, 2026 - Use cautionDrug
Preferred Pharmaceuticals, Inc. recalls Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by
Preferred Pharmaceuticals recalls specific lots of Ondansetron ODT 4mg tablets because blister packs are not fully sealed, risking lost medication.
Preferred PharmaceuticalsNov 17, 2025 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited,
Preferred Pharmaceuticals recalls 300mg Clindamycin capsules due to current Good Manufacturing Practice deviations. Check your lot numbers for details.
Preferred PharmaceuticalsApr 18, 2025 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Ibuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy's Laboratories,
Preferred Pharmaceuticals recalls 30-tablet Motrin Ibuprofen 400mg bottles made by Dr. Reddy's Laboratories with potential impurities. Consumers should check lot numbers and contact the company for details.
Preferred PharmaceuticalsAug 8, 2024 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Duloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDC 68788-9301-03
Preferred Pharmaceuticals recalls 30mg Duloxetine bottles due to potential N-nitroso impurity above FDA limits. This may pose health risks. Consumers should contact the company for details.
Preferred PharmaceuticalsMay 10, 2024 - Lower riskDrug
Preferred Pharmaceuticals, Inc. recalls Tizanidine Hydrochloride Tablet 4mg, packaged in a) 20 count-bottles (NDC 68788-7781-2), b)30-count bottles (NDC:
Preferred Pharmaceuticals recalls 4mg Tizanidine Hydrochloride tablets due to failed stability specifications. Products may degrade over time, posing risks to medication effectiveness. Check NDC codes and expiration dates for affected lots.
Preferred PharmaceuticalsJun 26, 2023 - Lower riskDrug
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tab, USP 0.25mg, (CIV), 30-count bottle, Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by:
Preferred Pharmaceuticals recalls 30-count 0.25mg Alprazolam tabs (NDC 68788-7594-3, Lot G1822K) due to potential cross-contamination from another product during manufacturing.
Preferred PharmaceuticalsMar 27, 2023 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Doxazosin Tablets, USP, 4 mg, 100-count bottle, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC
Preferred Pharmaceuticals recalls 4 mg Doxazosin tablets due to manufacturing quality deviations. This affects specific lots produced by Accord Healthcare. Consumers should contact the manufacturer for details.
Preferred PharmaceuticalsMar 23, 2023 - Use cautionDrug
Preferred Pharmaceuticals, Inc. recalls Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED
Preferred Pharmaceuticals recalls 100mg Allopurinol tablets due to small green plastic piece in some bottles. Consumers should check product details and contact the company for guidance.
Preferred PharmaceuticalsJan 16, 2023 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5, Pkg Size: 90, NDC: 68788-7758-09.
Preferred Pharmaceuticals recalls Losartan Potassium & HCTZ 50mg/12.5mg tablets with AZIDO impurities above safe levels. Consumers should check lot numbers and contact the company for details.
Preferred PharmaceuticalsMay 3, 2022 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
Preferred Pharmaceuticals recalls 30-count Losartan Potassium 50mg tablets (Lupin Pharmaceuticals) with high azido impurity levels. Consumers should check lot numbers on packaging for affected batches.
Preferred PharmaceuticalsApr 12, 2022 - Lower riskDrug
Preferred Pharmaceuticals, Inc. recalls Preferred Pharmaceuticals, Inc. The Physician's Solution., Lansoprazole Delayed-Release Capsules, 15mg, Generic for
Preferred Pharmaceuticals is recalling 15mg Lansoprazole Delayed-Release Capsules (90-count) after stability testing showed dissolution problems. This may affect drug effectiveness.
Preferred PharmaceuticalsMar 28, 2022 - Use cautionDrug
Preferred Pharmaceuticals, Inc. recalls Diclofenac Sodium Topical Solution 1.5% w/w, Generic for Pennsaid, 150 ml bottle, Rx Only, Mfg: Sola Pharmaceutical,
Preferred Pharmaceuticals recalls 528 bottles of Diclofenac Sodium Topical Solution due to CGMP deviations. Check lot numbers and expiration dates for affected units.
Preferred PharmaceuticalsMar 24, 2022 - Lower riskDrug
Preferred Pharmaceuticals, Inc. recalls Econazole Nitrate Cream, 1%, Generic for Spectazole, 30 gm tube, Rx Only, Preferred Pharmaceuticals, Inc., The
Preferred Pharmaceuticals is recalling Econazole Nitrate Cream 1% (30g tube) because Teligent Pharma discontinued its stability study program, affecting product safety.
Preferred PharmaceuticalsMar 24, 2022 - Use cautionDrug
Preferred Pharmaceuticals, Inc. recalls Clobetasol Propionate Lotion 0.05%, Generic for Temovate, 118 mL bottle, Rx Only, Mfg: Teligent Pharma, Inc., PREFERRED
Preferred Pharmaceuticals recalls 1568 bottles of Clobetasol Propionate Lotion due to CGMP deviations. Check lot numbers and expiration dates for details.
Preferred PharmaceuticalsMar 23, 2022 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Alprazolam Tablets, USP 1mg, Generic for Xanax, Pkg Size: a) 30 tablets per bottle, NDC: 68788-6381-03, b) 60 tablets
Preferred Pharmaceuticals recalls Alprazolam 1mg tablets (NDCs 68788-6381-03, 06, 09) for CGMP deviations. Consumers should check lot numbers and expiration dates on packaging.
Preferred PharmaceuticalsFeb 22, 2022 - Lower riskDrug
Preferred Pharmaceuticals, Inc. recalls Diclofenac Sodium Topical Solution, 1.5% w/w, packaged in 150 mL bottles, Rx only, Mfg: SOLA Pharmaceuticals Preferred
Preferred Pharmaceuticals recalls 150mL Diclo: Leaking bottles risk contamination. Rx-only product with NDC 68788-7707-01. Stop using if leaking.
Preferred PharmaceuticalsNov 29, 2021 - Lower riskDrug
Preferred Pharmaceuticals, Inc. recalls Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only,
Preferred Pharmaceuticals recalls Metformin XR tablets due to NDMA impurity exceeding safe limits. This may pose health risks with long-term use. Affected lots include C2520W through G2720A.
Preferred PharmaceuticalsApr 28, 2021 - Lower riskDrug
Preferred Pharmaceuticals, Inc. recalls Cephalexin for Oral Suspension, Generic for Keflex, USP, Powder for Oral Suspension, 250 mg/5mL, Pkg Size 100, Rx only,
Preferred Pharmaceuticals recalls Cephalexin oral suspension (250mg/5mL) for potential impurities found during testing. This is a repackaged product from Ascend Laboratories. No immediate action needed as it's prescription-only.
Preferred PharmaceuticalsApr 12, 2021 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Metformin HCl Extended Release Tablets USP 500 mg, Generic for : Glucophage XR, Pkg Size 100, Mfg: Time-Cap Labs, Inc.;
Preferred Pharmaceuticals recalls Metformin HCl Extended Release Tablets (Glucophage XR) due to excessive N-Nitrosodimethylamine (NDMA) detected in some batches. This chemical poses a potential cancer risk. Consumers should check their product details and contact the company for instructions.
Preferred PharmaceuticalsNov 1, 2020 - Use cautionDrug
Preferred Pharmaceuticals, Inc. recalls Nature-Throid, 1 Grain, 65 mg (Thyroid U.S.P. 1 gr. (65mg)/Liothyronine (T3) 9mcg/Levothyroxine (T4) 38mcg, packaged in
Preferred Pharmaceuticals recalls Nature-Throid 1 Grain tablets due to CGMP deviations. Check lot numbers A0220Q and K15171 for expiration date 10/31/2020.
Nature-ThroidSep 2, 2020 - UnratedDrug
Preferred Pharmaceuticals, Inc. recalls Lidothol Patch, Lidocaine 4.5% & Menthol 5%, In each patch: lidocaine 4.5% topical anesthetic, menthol 5% topical
Preferred Pharmaceuticals recalls Lidothol Patches due to lost batch records. Check lot numbers H0218Z, H1518J, I2018L, J2918C, L1018Q, A0419M, G0519G.
LidotholJul 1, 2020 - Stop using nowDrug
Preferred Pharmaceuticals, Inc. recalls Metformin HCl Extended Release Tablets, USP, 500 mg, Generic for Glucophage XR, Pkg Size 100, Mfg: Time-Cap, Labs Inc.,
Preferred Pharmaceuticals recalls 100-count Metformin HCl Extended Release Tablets due to detected N-Nitrosodimethylamine (NDMA) levels exceeding FDA safety limits. Consumers should stop using affected products immediately.
Preferred PharmaceuticalsJun 17, 2020 - UnratedDrug
Preferred Pharmaceuticals, Inc recalls Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 300 mg, Rx Only, a) 14 count bottles (NDC: 68788-6382-1), b) 30
Preferred Pharmaceuticals recalls ranitidine tablets due to NDMA impurity detected in product. This recall affects specific bottle sizes and lot numbers.
Preferred PharmaceuticalsJan 7, 2020 - Stop using nowDrug
Preferred Pharmaceuticals, Inc recalls Ranitidine Tablets, USP 150 mg, OTC, a.) 30 count bottle (NDC 68788-7078-03), b.) 60 count bottle (NDC 68788-7078-06),
Preferred Pharmaceuticals recalls 150mg Ranitidine Tablets due to detected NDMA impurity. Consumers should stop using these products immediately.
Preferred PharmaceuticalsDec 2, 2019 - Use cautionDrug
Preferred Pharmaceuticals, Inc recalls Ibuprofen Oral Suspension USP, 100 mg/5mL, 4 fl.oz. 118 mL, Rx only, Preferred Pharmaceuticals, Inc., Anaheim, CA. Mfg:
Preferred Pharmaceuticals recalls ibuprofen oral suspension with possible plastic particles. Consumers should check lot numbers and contact the company for details.
Preferred PharmaceuticalsNov 21, 2019 - UnratedDrug
Preferred Pharmaceuticals, Inc recalls Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc.,
Preferred Pharmaceuticals recalls 180mg Fexofenadine HCl tablets (NDC 68788-6848-09) with failed impurities specifications. Consumers should contact the company for details.
Preferred PharmaceuticalsAug 29, 2019 - UnratedDrug
Preferred Pharmaceuticals, Inc recalls Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 g Tube,
Preferred Pharmaceuticals recalls Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg ophthalmic ointment due to insufficient quality assurance controls in manufacturing. This product is available in specific lot numbers and expiration dates.
Preferred PharmaceuticalsJul 18, 2019 - UnratedDrug
Preferred Pharmaceuticals, Inc recalls Robafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextromethorphan HBr, USP 10mg,/Guaifenesin, USP
Preferred Pharmaceuticals recalls Robafen DM (generic for Robitussin DM) due to potential contamination with Burkholderia cepacia and Ralstonia pickettii. Affected lots were manufactured between February 2020 and July 2020. Consumers should contact the manufacturer for details.
Preferred PharmaceuticalsJun 10, 2019 - UnratedDrug
Preferred Pharmaceuticals, Inc recalls Losartan Potassium Tab. USP 50mg, a) 30 count bottle (NDC 68788-0048-03) and b) 90 count bottle (NDC 68788-0048-09), Rx
Preferred Pharmaceuticals recalls 50mg Losartan Potassium tablets due to FDA-confirmed impurity NMBA above safe levels. Consumers should check NDC codes and contact the company for details.
Preferred PharmaceuticalsApr 30, 2019 - UnratedDrug
Preferred Pharmaceuticals, Inc recalls Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC:
Preferred Pharmaceuticals recalls Losartan Potassium Tablets (50mg) with NDC 68788-0048-03 and 68788-0048-09 due to presence of an impurity that may pose health risks. Affected products include 30-count and 90-count bottles.
Preferred PharmaceuticalsMar 6, 2019 - UnratedDrug
Preferred Pharmaceuticals, Inc recalls Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250
Preferred Pharmaceuticals recalls 320mg Valsartan Tablets due to detected carcinogen impurity in manufacturing. Affected lots include NDC 68788-6882-9, Lot # G2017F. Consumers should contact the company for details.
Preferred PharmaceuticalsAug 15, 2018
Preferred Pharmaceuticals, Inc. recall questions
How many recalls has Preferred Pharmaceuticals, Inc. had?
56 recalls from Preferred Pharmaceuticals, Inc. are on record with U.S. safety agencies, from 2018–2026.
What is the most recent Preferred Pharmaceuticals, Inc. recall?
Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A.,, dated Sep 28, 2026. Every Preferred Pharmaceuticals, Inc. recall is listed on this page, newest first.
Why are Preferred Pharmaceuticals, Inc. products recalled?
The most common reasons on record: CGMP Deviations (4); CGMP Deviations: Presence of NDMA impurity detected in product. (3); CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits (2).
What should I do if I have a recalled Preferred Pharmaceuticals, Inc. product?
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
How do I get alerts for new Preferred Pharmaceuticals, Inc. recalls?
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.